Merus (MRUS) Short Interest Ratio & Short Volume → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free MRUS Stock Alerts $43.40 -0.51 (-1.16%) (As of 03:52 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Merus Short Interest DataCurrent Short Interest3,380,000 sharesPrevious Short Interest3,290,000 sharesChange Vs. Previous Month+2.74%Dollar Volume Sold Short$151.80 millionShort Interest Ratio5.3 Days to CoverLast Record DateApril 30, 2024Outstanding Shares58,690,000 sharesPercentage of Shares Shorted5.76%Today's Trading Volume658,793 sharesAverage Trading Volume609,644 sharesToday's Volume Vs. Average108% Short Selling Merus ? Sign up to receive the latest short interest report for Merus and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMRUS Short Interest Over TimeMRUS Days to Cover Over TimeMRUS Percentage of Float Shorted Over Time Ad Stansberry Research41 banks launch ‘crypto dollar’Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). Merus Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,380,000 shares $151.80 million +2.7%N/A5.3 $44.91 4/15/20243,290,000 shares $135.78 million -4.4%N/A5.7 $41.27 3/31/20243,440,000 shares $154.90 million -16.1%N/A5.8 $45.03 3/15/20244,100,000 shares $179.99 million -8.1%N/A7.1 $43.90 2/29/20244,460,000 shares $216.22 million -6.1%N/A8 $48.48 2/15/20244,750,000 shares $206.48 million +2.4%N/A8.9 $43.47 Get the Latest News and Ratings for MRUS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Merus and its competitors with MarketBeat's FREE daily newsletter. 1/31/20244,640,000 shares $165.56 million -1.1%N/A10 $35.68 1/15/20244,690,000 shares $152.85 million -14.4%N/A10.3 $32.59 12/31/20235,480,000 shares $150.70 million -2.3%N/A12.7 $27.50 12/15/20235,610,000 shares $141.60 million -12.5%N/A13.1 $25.24 11/30/20236,410,000 shares $158.58 million -2.3%N/A15.9 $24.74 11/15/20236,560,000 shares $157.24 million +0.3%N/A19.1 $23.97 10/31/20236,540,000 shares $131.52 million +28.0%N/A17.8 $20.11 10/15/20235,110,000 shares $107.82 million +9.9%N/A15.3 $21.10 9/30/20234,650,000 shares $109.65 million +8.1%N/A16.7 $23.58 9/15/20234,300,000 shares $104.79 million +0.2%N/A17.2 $24.37 8/31/20234,290,000 shares $95.97 million +5.7%N/A16.8 $22.37 8/15/20234,060,000 shares $87.66 million -2.2%N/A16.4 $21.59 7/31/20234,150,000 shares $108.90 million -2.8%N/A14.9 $26.24 7/15/20234,270,000 shares $116.53 million -4.5%11.9%13.5 $27.29 6/30/20234,470,000 shares $117.70 million -8.2%12.4%10.2 $26.33 6/15/20234,870,000 shares $129.88 million -1.4%13.5%10.4 $26.67 5/31/20234,940,000 shares $107.30 million +1.4%13.7%11 $21.72 5/15/20234,870,000 shares $102.08 million +7.5%13.5%10.7 $20.96 4/30/20234,530,000 shares $86.89 million +42.9%12.5%10.6 $19.18 4/15/20233,170,000 shares $68.95 million +6.0%8.8%7.8 $21.75 3/31/20232,990,000 shares $55.02 million +4.9%8.3%10.5 $18.40 3/15/20232,850,000 shares $57.80 million +2.9%7.8%11.9 $20.28 2/28/20232,770,000 shares $52.82 million -1.1%7.6%11.9 $19.07 2/15/20232,800,000 shares $52.11 million -2.8%7.7%12.8 $18.61 1/31/20232,880,000 shares $44.93 million -3.4%7.8%12.7 $15.60 1/15/20232,980,000 shares $45.98 million -1.3%N/A10.2 $15.43 12/30/20223,020,000 shares $46.72 million +13.5%N/A9.9 $15.47 12/15/20222,660,000 shares $35.32 million -4.0%N/A8.3 $13.28 11/30/20222,770,000 shares $42.52 million -3.5%N/A8.3 $15.35 11/15/20222,870,000 shares $52.61 million -1.7%N/A8.7 $18.33 10/31/20222,920,000 shares $59.86 million -1.0%8.4%8.9 $20.50 10/15/20222,950,000 shares $64.90 million +7.3%8.6%11.9 $22.00 9/30/20222,750,000 shares $55.08 million +10.0%8.0%10.5 $20.03 9/15/20222,500,000 shares $59.15 million +2.5%7.3%8.4 $23.66**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report 8/31/20222,440,000 shares $57.78 million +0.8%7.2%8.7 $23.68 8/15/20222,420,000 shares $62.24 million -21.7%7.2%6.8 $25.72 7/31/20223,090,000 shares $74.72 million -9.9%9.6%8.4 $24.18 7/15/20223,430,000 shares $93.91 million -11.4%10.7%9 $27.38 6/30/20223,870,000 shares $87.62 million -1.8%12.0%10.3 $22.64 6/15/20223,940,000 shares $77.70 million -5.1%12.2%11.4 $19.72 5/31/20224,150,000 shares $77.02 million +11.0%12.9%14.2 $18.56 5/15/20223,740,000 shares $59.73 million +20.3%11.6%17.5 $15.97 4/30/20223,110,000 shares $63.44 million +15.2%9.7%16.9 $20.40 4/15/20222,700,000 shares $70.63 million +0.4%8.4%17.1 $26.16 3/31/20222,690,000 shares $71.12 million -1.8%8.4%18.5 $26.44 3/15/20222,740,000 shares $71.79 million +10.9%8.6%17.6 $26.20 2/28/20222,470,000 shares $69.38 million +1.2%7.7%12.9 $28.09 2/15/20222,440,000 shares $65.49 million -1.6%7.8%12.4 $26.84 1/31/20222,480,000 shares $61.03 million +1.6%8.6%11.4 $24.61 1/15/20222,440,000 shares $69.44 million +2.5%7.2%9.8 $28.46 12/31/20212,380,000 shares $75.68 million +5.3%7.2%8.4 $31.80 12/15/20212,260,000 shares $68.91 million +2.3%6.9%4.1 $30.49 11/30/20212,210,000 shares $57.48 million -7.1%6.7%4.2 $26.01 11/15/20212,380,000 shares $70.59 million -7.8%7.3%4.7 $29.66 10/29/20212,580,000 shares $72.37 million -0.8%8.4%5.1 $28.05 10/15/20212,600,000 shares $80.31 million +23.8%8.5%5.2 $30.89 9/30/20212,100,000 shares $46.20 million -1.9%6.9%4.5 $22.00 9/15/20212,140,000 shares $54.70 million -5.3%7.0%9.1 $25.56 8/31/20212,260,000 shares $58.94 million -16.0%7.4%9.4 $26.08 8/13/20212,690,000 shares $52.72 million +26.3%8.8%9.7 $19.60 7/30/20212,130,000 shares $36.64 million +2.9%7.2%7.4 $17.20 7/15/20212,070,000 shares $35.42 million +24.7%7.1%8.1 $17.11 6/30/20211,660,000 shares $34.98 million +16.9%5.7%6.8 $21.07 6/15/20211,420,000 shares $30.39 million +7.6%4.8%7.3 $21.40 5/28/20211,320,000 shares $27.92 million +41.7%4.5%6.9 $21.15 5/14/2021931,400 shares $20.49 million +2.8%N/A6.1 $22.00 4/30/2021906,500 shares $19.66 million +6.2%N/A7.6 $21.69 4/15/2021853,600 shares $19.82 million +0.6%N/A5.7 $23.22 3/31/2021848,900 shares $17.17 million +15.7%N/A4.6 $20.23 3/15/2021733,800 shares $16.81 million +7.8%N/A4.3 $22.91 2/26/2021680,900 shares $13.96 million -1.0%N/A4.3 $20.50 2/12/2021687,400 shares $16.39 million -2.3%N/A3.7 $23.84 1/29/2021703,500 shares $18.73 million +67.8%N/A3.9 $26.62 1/15/2021419,300 shares $9.60 million +1.2%N/A2.6 $22.89 12/31/2020414,400 shares $7.30 million -6.2%2.2%3.4 $17.61 12/15/2020441,900 shares $7.45 million -1.3%2.3%4.1 $16.87 11/30/2020447,700 shares $7.39 million +53.0%2.3%3.9 $16.50 11/15/2020292,600 shares $3.84 million -5.1%1.5%3 $13.14 10/30/2020308,400 shares $3.98 million +40.5%1.6%4.3 $12.89 10/15/2020219,500 shares $2.95 million -7.9%1.2%3.2 $13.44 9/30/2020238,200 shares $2.86 million +13.9%1.2%3.9 $12.00 9/15/2020209,200 shares $2.56 million -16.4%1.1%3 $12.25 8/31/2020250,200 shares $3.02 million -9.1%1.3%3.5 $12.07 8/14/2020275,100 shares $3.54 million -1.6%1.4%2.5 $12.87**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report 7/31/2020279,700 shares $3.83 million +8.4%1.5%2.4 $13.69 7/15/2020258,100 shares $3.65 million -0.1%1.4%2.1 $14.14 6/30/2020258,300 shares $3.82 million -10.4%1.4%1.6 $14.80 6/15/2020288,300 shares $4.37 million +14.1%1.5%1.8 $15.15 5/29/2020252,600 shares $3.57 million +11.7%1.3%1.6 $14.14 5/15/2020226,100 shares $3.30 million -0.7%1.2%2.1 $14.61 4/30/2020227,600 shares $3.38 million +6.1%1.2%2.3 $14.84 4/15/2020214,600 shares $2.53 million -32.8%1.0%2.2 $11.80 3/31/2020319,100 shares $5.19 million +6.3%1.6%4.7 $16.25 3/13/2020300,200 shares $3.63 million +0.3%1.5%7.7 $12.10 2/28/2020299,400 shares $3.62 million -3.7%1.5%4.2 $12.09 2/14/2020311,000 shares $4.92 million -15.6%1.5%3.8 $15.82 1/31/2020368,500 shares $6.25 million -15.6%2.0%4.8 $16.96 1/15/2020436,600 shares $7.81 million +21.1%2.4%3.7 $17.89 12/31/2019360,500 shares $6.14 million +4.3%2.0%3.2 $17.02 8/15/2019303,100 shares $4.64 million -0.6%3.0%10.4 $15.30 MRUS Short Interest - Frequently Asked Questions What is Merus' current short interest? Short interest is the volume of Merus shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 3,380,000 shares of MRUS short. Learn More on Merus' current short interest. What is a good short interest ratio for Merus? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRUS shares currently have a short interest ratio of 5.0. Learn More on Merus's short interest ratio. Which institutional investors are shorting Merus? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Merus: StemPoint Capital LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Merus' short interest increasing or decreasing? Merus saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 3,380,000 shares, an increase of 2.7% from the previous total of 3,290,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Merus' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Merus: Bausch Health Companies Inc. (5.73%), MoonLake Immunotherapeutics (14.00%), Maravai LifeSciences Holdings, Inc. (6.66%), Amicus Therapeutics, Inc. (9.71%), Avidity Biosciences, Inc. (11.91%), MorphoSys AG (0.83%), Janux Therapeutics, Inc. (9.55%), TG Therapeutics, Inc. (27.08%), Rhythm Pharmaceuticals, Inc. (17.37%), Dyne Therapeutics, Inc. (18.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Merus stock? Short selling MRUS is an investing strategy that aims to generate trading profit from Merus as its price is falling. MRUS shares are trading down $0.51 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Merus? A short squeeze for Merus occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRUS, which in turn drives the price of the stock up even further. How often is Merus' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRUS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Bausch Health Companies Short Interest Data MoonLake Immunotherapeutics Short Interest Data Maravai LifeSciences Short Interest Data Amicus Therapeutics Short Interest Data Avidity Biosciences Short Interest Data MorphoSys Short Interest Data Janux Therapeutics Short Interest Data TG Therapeutics Short Interest Data Rhythm Pharmaceuticals Short Interest Data Dyne Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MRUS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDems have chosen Biden replacement?Paradigm PressDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsWarren Buffett's "mystery stock"Stansberry Research